PMI reports strong Q3 performance: Smoke-free product users reach 36.5 million, ZYN sales up 41.4% in the US

Oct.22.2024
PMI reports strong Q3 performance: Smoke-free product users reach 36.5 million, ZYN sales up 41.4% in the US
Philip Morris International (PMI) announced a strong performance in its Q3 2024 report, with nearly 400 billion units shipped worldwide.

Philip Morris International (PMI) released its third-quarter performance report on 22 October, revealing that it shipped nearly 40 billion units of its non-tobacco products in 92 markets worldwide during the period.

 

The Non-Smoke business accounted for 38% of PMI's total net sales and 40% of its gross profit, increasing by 1.9 and 2.2 percentage points respectively compared to the same quarter last year. Net sales and gross profit grew by 14.2% and 15.9% respectively. The total number of users of Smokeless products reached 36.5 million.

 

PMI reports strong Q3 performance: Smoke-free product users reach 36.5 million, ZYN sales up 41.4% in the US
Report | Image source: PMI official website

 

IQOS, accounting for nearly 77% of global sales of HNB products.

 

In its performance report, PMI stated that IQOS, as the second largest nicotine brand, saw a further increase in market share, driving growth in the HNB product category, accounting for nearly 77% of global sales of similar products. Adjusted market sales volume (excluding inventory fluctuations) is estimated to have increased by 14.8%.

 

Japan Market: ILUMA i drives growth of IQOS, with adjusted sales increasing by 14.3%, marking the eighth consecutive quarter of double-digit growth. IQOS's HTU market share has increased to nearly 30%, driving the category to capture at least 50% of nicotine consumption share in 8 major cities including Tokyo and Yokohama.

 

European Market: IQOS increases market share of HTU to 9.5%, with adjusted sales growth accelerating to 11.3%. The Italian market shows strong recovery, with growth exceeding 20% in markets such as Greece and Germany. IQOS continues to expand its range of consumable products, with DELIA and LEVIA now available in 9 markets and plans for further expansion in the fourth quarter.

 

Outside of Europe and Japan: IQOS has seen significant market share growth in major cities around the world such as Seoul, Toronto, Mexico City, Cairo, and Jakarta, particularly in Indonesia, due to expanded geographic coverage and product offerings.

 

VEEV: Leading the switchable cartridge brand in European markets such as Italy and Romania.

 

According to PMI, in the European market, VEEV's closed-loop refill products continue to capture market share from disposable products and are in a leading position. VEEV is leading the closed-loop refill market in several markets including Italy, Romania, and the Czech Republic.

 

ZYN: Sales in the US market reach 149 million cans and have penetrated over 30 markets.

 

The shipment volume of canned ZYN nicotine pouches increased by 24.7%, driven mainly by the growth of ZYN nicotine pouches in the United States - with US shipments reaching 149.1 million cans, a 41.4% year-on-year increase. The growth in markets outside of the US was nearly 70%, with significant contributions from Pakistan and South Africa. ZYN has now entered 30 markets, including recently entering Greece and the Czech Republic.

 

PMI CEO Jacek Olczak stated that in the third quarter, we achieved extremely strong performance, achieving record quarterly net income and earnings per share. This reflects strong momentum in all regions and categories, with accelerated in-market sales growth of IQOS, strong sales of ZYN, and steady performance of combustible products. Due to our strong performance year-to-date, we are raising our full-year adjusted diluted earnings per share growth expectations to a range of 14% to 15% (excluding currency impacts).

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.